MarketCap
Facebook
X
Telegram
Amgen P/S Ratio | AMGN
Annual P/S Ratio Amgen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.4 | 4.68 | 5.5 | 4.9 | 4.89 | 4.95 | 5.86 | 5.15 | 6.12 | 5.02 | 5.34 | 5.76 | 4.87 | 3.83 | 3.97 | 3.24 | 3.48 | 3.15 | 4.31 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.12 | 3.15 | 4.76 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Celsion Corporation
CLSN
|
26.1 | - | -6.63 % | $ 13.9 M |  USA |
 |
FSD Pharma
HUGE
|
172 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
Dynavax Technologies Corporation
DVAX
|
6.24 | - | - | $ 2.02 B | USA |
 |
I-Mab
IMAB
|
12.5 | - | - | $ 866 M |  China |
 |
AgeX Therapeutics
AGE
|
9.24 | - | -10.17 % | $ 12.2 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | USA |
 |
Qilian International Holding Group Limited
QLI
|
1.19 | - | -6.08 % | $ 184 M | China |
 |
Happiness Biotech Group Limited
HAPP
|
0.429 | - | 1.35 % | $ 17.8 M | China |
 |
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B |  France |
 |
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M |  Germany |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | USA |
 |
Abcam plc
ABCM
|
13.7 | - | - | $ 4.9 B |  Britain |
 |
Завод ДИОД
DIOD
|
1.28 | - | - | - |  Russia |
 |
Midatech Pharma plc
MTP
|
240 | - | -18.52 % | $ 27.3 M | Britain |
 |
MorphoSys AG
MOR
|
2.62 | - | 2.43 % | $ 254 M | Germany |
 |
Codexis
CDXS
|
1.57 | $ 1.46 | 2.82 % | $ 127 M | USA |
 |
Ardelyx
ARDX
|
3.98 | $ 3.78 | 1.89 % | $ 911 M | USA |
 |
Affimed N.V.
AFMD
|
13.1 | - | -34.95 % | $ 21.5 M | Germany |
 |
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 23.9 | 1.01 % | $ 3.04 B | USA |
 |
Assembly Biosciences
ASMB
|
4.27 | $ 36.6 | 1.3 % | $ 410 M | USA |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
13.9 | - | -1.58 % | $ 28.1 M | China |
 |
Celyad Oncology SA
CYAD
|
21.3 K | - | - | $ 12.5 M |  Belgium |
 |
Generation Bio Co.
GBIO
|
30.3 | - | - | $ 344 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
2.54 | - | -4.36 % | $ 27 M | USA |
 |
Axsome Therapeutics
AXSM
|
13.6 | $ 206.68 | 0.16 % | $ 10.3 B | USA |
 |
GlycoMimetics
GLYC
|
20.1 K | - | 9357.83 % | $ 1.01 B | USA |
 |
AnaptysBio
ANAB
|
6.48 | $ 56.8 | 0.94 % | $ 1.63 B | USA |
 |
Aeterna Zentaris
AEZS
|
1.54 | - | 5.93 % | $ 314 M | Canada |
 |
BioMarin Pharmaceutical
BMRN
|
3.63 | $ 66.53 | 0.15 % | $ 12.8 B | USA |
 |
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
93.5 | - | - | $ 1.01 B | USA |
 |
Bicycle Therapeutics plc
BCYC
|
4.84 | $ 4.3 | 1.42 % | $ 298 M | Britain |
 |
ChromaDex Corporation
CDXC
|
4.32 | - | -0.88 % | $ 598 M | USA |